Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
VOYA Voya Financial rises 13 percent after Q4 2025 results despite EPS miss and modest year over year revenue growth Blk SciTech BST Stock Consolidation or Breakout Wavering 20260420 RARE Ultragenyx Pharmaceutical delivers 202 percent year over year revenue growth shares tick modestly higher post earnings JXG JX delivers 565 percent year over year Q1 2025 revenue growth as shares hold steady iShares Core SP SmallCap ETF IJR Poised for Outperformance as US SmallCap Rotation Accelerates The organic vs inorganic growth story at Real RMSG TISI Team shares rise 093 percent after posting negative 121 EPS for its Q4 2025 quarter The one metric that defines Unity Bancorp UNTY success 060 20260506 OEC Orion SA posts Q1 2026 loss against profit estimates shares dip 132 today Tantech TANH Stock Slides 051 Support at 037 20260518 Getty GTY Q1 2026 Earnings Beat Revenue NA EPS 043 Why Nova NVA Just Dropped 250 What to Watch 20260515 San Francisco Giants Prospect Jonah Cox Leads Eastern League in Batting Average Bolstering Trade Value UK Services Sector Activity Posts Sharpest Decline in a Decade Amid Political and Geopolitical Uncertainty Nvidia Shares Dip Despite Wave of Analyst PriceTarget Hikes Fed Minutes Reveal Growing Hawkish Sentiment Amid IranInduced Inflation Concerns Nvidia Shares Dip Despite Record 745 Billion Profit and 102 Billion Buyback Announcement BWFG Q1 2026 Earnings EPS Surpasses Estimates by 13 UZF Q1 2026 Earnings EPS Surges Past Estimates by 43 MANH Q1 2026 Earnings Earnings Beat Driven by Strong Cloud Momentum Nayax Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher VEON Q1 2026 Earnings EPS Beat Underpins Operational Resilience Intellicheck IDN Shares Slide 385 as Support Level Nears Critical Test BWX Technologies BWXT Edges Higher in LowVolume Trading Tests Key Support Zone CS Disco Inc LAW Edges Lower as Shares Test Key Support Levels ProQR Therapeutics PRQR Holds Steady Near 157 as Uplift Potential Remains